STAT stories you may have missed

A deep dive into Bernie Sanders’ plan for shaking up the drug industry. 

An inside look at the lottery determining which children get access to Zolgensma, AveXis’ $2.1 million gene therapy. 

Pharmalot has the latest on why the U.S. embassy is in a tiff with the Netherlands over drug patents. 

There’s a new splashy company promising to leverage real-world-evidence for pharma. 

Why would a biotech company bet on failed drugs? 

Pharma is taking Canada to task over its newly unveiled drug pricing regulations.